Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 48, pseudogene (RNU1-48P) is a human gene classified as a pseudogene of the U1 small nuclear RNA gene family[1][2]. U1 snRNAs are essential noncoding RNAs involved in the spliceosome for pre-mRNA splicing, but pseudogenes like RNU1-48P generally contain mutations or sequence disruptions that prevent them from encoding functional U1 snRNA molecules or proteins[2][1]. However, some U1 snRNA pseudogenes are transcribed into RNA and can be recruited into ribonucleoprotein complexes, with potential, though largely uncharacterized, regulatory functions in gene expression[2]. Currently RNU1-48P is not considered a therapeutic target, does not interact with drugs or act as a biomarker, and is primarily annotated as a genomic element of uncertain function. As with other pseudogenes, its presence mainly reflects genomic evolution, and its classification as a target is likely incorrect[1][2][6].
Not applicable (not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 48, pseudogene (RNU1-48P).